Conversely, younger patients with non-palpable tumors, associated with lower PSA levels and more favorable grade groups, are less likely to have PLNI and to experience PCa progression, representing a more favorable prognostic group. This evidence concerns the gene KLK3 and posterior cortical atrophy.